Scientists have presented a new approach to cancer treatment using mast cells, which are immune cells known for their ability ...

A new study published in the International Journal of General Medicine showed that by focusing on mast cells and inflammatory ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on ...

Long COVID, also called post-acute COVID syndrome, affects 5–50% of people after SARS-CoV-2 infection and can involve ...

Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8th at 8:00am ET to present updated data from the BEACON study in CSU and the open-label extension study ...

The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.

(n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points ...

Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock rose 4.9% in after-hours trading Wednesday following the ...

AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...

As of Thursday, January 08, Jasper Therapeutics, Inc.’s JSPR share price has dipped by 14.63%, which has investors questioning if this is right time to buy.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...